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The Sleeping Beauty (SB) transposon (Tn) system is a nonviral gene delivery tool that has widespread application for transfer of therapeutic genes
into themammalian genome. To determine its utility as a gene delivery system, it was important to assess the epigenetic modifications associated with
SB insertion into the genome and potential inactivation of the transgene. This study investigated the DNAmethylation pattern of an SB Tn as well as
the flanking genomic region at insertion sites in themouse genome. The ubiquitousROSA26 promoter and an initial part of the eGFP coding sequence
in the SB Tn exhibited high levels of CpG methylation in transgenic mouse lines, irrespective of the chromosomal loci of the insertion sites. In
contrast, no detectable CpG methylation in the endogenous mouse ROSA26 counterpart was observed in the same animals. Furthermore, significant
hypomethylation was detected in neighboring chromosomal sequences of two unique SB Tn insertions compared to wild-type patterns. Taken
together, these results suggest that SB Tn insertions into the mouse genome can be discriminated by DNA methylation machinery from an identical
endogenous DNA sequence and can profoundly alter the DNA methylation status of the transgene cargo as well as flanking host genomic regions.
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element resurrected by genetic correction of accumulated mu-
tations using a consensus sequence derived from inactive
salmonoid-type members of the Tc1/mariner superfamily of
transposons [1]. The native form of the SB Tn consisted of ter-
minal inverted repeat/direct repeat sequences (IR/DRs) flanking
a gene encoding the obligate SB transposase that mediates the
insertion of the Tn into the host genome by a cut-and-paste
mechanism. For gene delivery or other applications such as in-
sertional mutagenesis, the transgene cassette for genomic in-
sertion is located between the IR/DRs, replacing the SB
transposase gene that is supplied as either a separate transgene
or mRNA. Target sites of SB transposition are invariably TA
dinucleotides that are duplicated during the insertion of the SB
Tn. It has been shown that the SB Tn system is functional in⁎ Corresponding author. Departments of Medicine and Genetics, Cell Biology,
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doi:10.1016/j.ygeno.2006.04.007cultured mammalian cells [1], mouse ES cells [2], mouse liver
[3], mouse germ lines [4], and single-cell embryos [5], sug-
gesting no indispensable host cofactors.
The potential of SB for delivering and stably integrating a
transgene into the mammalian host genome has been demon-
strated in vitro as well as in vivo [1,3]. If the SB Tn is to be used
for therapeutic gene delivery, it is critical to ensure the long-
term, stable expression of the transposed transgene within the
host genome. Heterologous DNA elements introduced into the
mammalian genome by various gene delivery systems are fre-
quently inactivated by de novo DNA methylation [6–8]. The
long terminal repeat (LTR) sequences of many retroviral vectors
are targets for de novo DNA methylation, which can lead to
silencing of transgenes or proviruses [6,7,9]. DNA methylation
is closely associated with the transcriptional repression of many
mammalian genes [10]. The direct correlation between repres-
sion of retroviruses in the host genome and mammalian CpG
methylation has been confirmed by reactivation following
treatments that induce genome-wide demethylation [11,12].
Mammalian CpGmethylation appears to play an essential role in
Fig. 1. Schematic map of the T/MPT-eGFP Tn and generation of transgenic mice
with mobilization of the SB Tn. (A) T/MPT-eGFP consists of typical IR/DR
sequences of SB at both ends, a splice acceptor (SA), a polyadenylation
sequence (pA), the ROSA26 promoter (black box), eGFP as the reporter gene,
and a splice donor (SD). (B) Doubly transgenic FVB/n mice were created by
crossing transgenic mice carrying a multicopy concatemer of T/MPT-eGFP on
chromosome 9 with mice carrying an SB10 transposase transgene on
chromosome 3. Outcrossing the doubly transgenic male mice to wild-type
female mice of the FVB/n strain resulted in progeny that had T/MPT-eGFP SB
insertions transposed from the original locus on chromosome 9 to other loci in
the mouse genome by the action of the SB10 transposase in the germ line of the
T/MPT-eGFP/SB10 males. The progeny carrying the new insertions were further
bred to generate the homo- or heterozygous animals for each of the different
integrations investigated in this study.
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development, genomic imprinting, and carcinogenesis. In fact,
partial or complete lack of DNA methyltransferase activity
results in dramatic changes associated with those biological
processes [13–15]. Reactivation of silent retroviral or retro-
transposon elements due to the lack of DNA methylation sug-
gests that it may have evolved as a basic defense mechanism to
prevent the harmful activity of mobile DNA elements within the
mammalian genome [16,17].
Previous studies of SB have focused on applications for the-
rapeutic gene delivery [3,18], improvement of insertion effi-
ciency [19,20], and the utilization of SB for insertional
mutagenesis in mouse [2,4,21,22]. Moreover, the precise target
site preference of SB-mediated insertion has also been studied
extensively to evaluate the possible application of the SB Tn
system for clinical gene therapy [23–25]. While viral vectors
exhibit a clear preference for transcriptionally active regions as
their target sites for integration [26,27], SB has displayed either
no significant preference for actively transcribed regions in the
host genome [21,24] or a very weak insertional bias toward
transcriptional units [25]. Most recently, SB has been used for
cancer gene discovery in the mouse genome in all tissue types
[28]. Thus, in addition to issues related to delivery and trans-
position of a transgene by SB, it is essential to characterize the
potential epigenetic modifications at the site of insertion as
well as within the flanking chromosomal regions. Epigenetic
changes such as DNA methylation could significantly influence
the transcriptional activity of the Tn transgene cargo and the
adjacent host genomic regions.
To identify a potential relationship between SB transposition
and DNA methylation, we investigated the CpG methylation
status of an inserted transgene (T/MPT-eGFP) and host genomic
flanking regions by bisulfite-mediated sequencing [29]. Our
results revealed that SB Tns inserted into the mouse genome
were heavily methylated in the ROSA26 promoter [30,31] and
eGFP (enhanced and farnesylated green fluorescent protein)
reporter gene, both of which were contained in SB. However,
the endogenous mouse ROSA26 promoter located at the native
chromosomal locus was devoid of CpG methylation in the same
transgenic animals carrying SB insertions. This is strong evi-
dence to suggest that the host cellular epigenetic modification
system can distinguish between an endogenous genomic se-
quence and the exogenous counterpart inserted via SB. In
addition, we detected hypomethylation or complete absence of
CpG methylation at two host genomic flanking regions that
were methylated in the wild-type mice. These results indicate
that SB Tns inserted into the mammalian genome can be the
target for significant modification of DNA methylation, po-
tentially altering gene expression.
Results
Transgenic mice generated with SB insertions in their genome
An SB Tn, T/MPT-eGFP, was originally constructed for
polyadenylation (poly(A))-gene-trap mutagenesis in mice
(MPT) [21,22]. Its mutagenic nature stems from its cargo of asplice acceptor, followed by stop codons in all three open
reading frames (ORFs), and a poly(A) signal that disrupts
transcription of an endogenous gene when T/MPT-eGFP is
inserted within an intron in the correct polarity relative to its
genomic promoter (Fig. 1A). As a reporter gene, eGFP was
incorporated into the construct under control of the ROSA26
promoter, which facilitates broad expression of transgenes in
mice [30,31]. The downstream splice donor was designed to
connect the eGFP ORF, which was devoid of its own poly(A)
signal, to an endogenous exon when the T/MPT-eGFP was
inserted into an intron in proper transcriptional orientation.
Doubly transgenic mice on a genetic background of the
FVB/n inbred strain were generated by crossing mice carrying
multicopy T/MPT-eGFP concatemer arrays on chromosome 9
with CAGGS-SB10 transgenic mice that expressed the SB10
transposase ubiquitously [22]. These doubly transgenic male
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progeny harboring the T/MPT-eGFP SB Tn mobilized from the
original locus of chromosome 9 in the germ-line cells of the
parental male mice (Fig. 1B). The new insertion sites of T/MPT-
eGFP were identified by splinkerette PCR [21]. The progeny
with novel insertion sites were subsequently bred on an FVB/n
background to generate mice heterozygous or homozygous for a
single unique SB insertion in the genome. In this study, trans-
genic mice harboring one of the T/MPT-eGFP insertions de-
signated, 01-0001, 01-0006, 01-0009, 01-0024, 01-0032, and
01-0041, were used [21]. Each of these insertions was flanked
by duplicated TA dinucleotides, which are the hallmark of
SB10-mediated transposition. Host genomic DNA sequences
adjacent to each insertion site investigated in this study are
accessible through the SB Tn database (http://mouse.ccgb.umn.
edu/transposon) [32].
High levels of DNA methylation within the inserted SB Tns
DNA methylation of immediate early promoters has been
shown to be important in regulating the transcriptional activity
of many mammalian genes [33,34]. Thus, to determine whether
an SB Tn inserted in the mouse genome was susceptible to
selective CpG methylation, genomic DNA isolated from tail
clips of T/MPT-eGFP transgenic mice was subjected to
bisulfite-mediated genomic sequencing [35,36]. By sequence
analysis using the Methprimer program [37], we identified an
∼1.7-kb region encompassing ROSA26 and eGFP of the T/
MPT-eGFP as a large CpG island [38]. We investigated the
DNA methylation status of ROSA26 and eGFP-coding se-
quence with bisulfite-PCR primers spanning a 3′ region of the
immediate early ROSA26 promoter (∼320 bp) and a 5′ region of
eGFP (∼170 bp) that contained a total of 57 CpG dinucleotides.
In all the inserted T/MPT-eGFP Tns characterized by each
distinct chromosomal position, the eGFP-coding sequence and
the 12 CpGs of ROSA26 at the boundary between ROSA26 and
eGFP were heavily methylated (Fig. 2). The remaining portion
of the ROSA26 promoter region examined was also extensively
methylated except for the Tns inserted in chromosomes 7 and 9,
indicating that the level of CpG methylation is modulated
according to chromosomal locus or genomic environment of SB
insertion. Homo- or heterozygosity at the identical insertion loci
did not influence the overall DNA methylation pattern observed
in the region.
Absence of DNA methylation at the endogenous ROSA26
counterpart of mouse genome
The ROSA26 promoter was derived from the 5′ regulatory
region of exon 1 of the mouse R26 locus [30,31]. If the endo-
genous ROSA26 sequence was inherently methylated in the
mouse genome, the hypermethylation pattern observed in the
ROSA26 portion of the T/MPT-eGFP in transgenic mice could
be attributed to an intrinsic characteristic of ROSA26. Therefore,
we examined the DNA methylation pattern of the endogenous
counterpart of ROSA26 located on mouse chromosome 6. Spe-
cific bisulfite-PCR primers were used to differentiate theendogenous counterpart from the ROSA26 of the inserted SB
Tn by selectively amplifying the endogenous genomic ROSA26
sequence in the same transgenic animals. Thus, the region exa-
mined by bisulfite-mediated sequencing had 5 more CpGs
derived specifically from the endogenous ROSA26 in addition to
the 36 in the 320-bp portion identical to the ROSA26 sequence
carried by the inserted T/MPT-eGFP (Fig. 3). Our results
indicated that the 41 CpG dinucleotides in the endogenous
ROSA26 at the native chromosomal locus were almost
completely free of DNA methylation in all the transgenic ani-
mals as well as in the three individual wild-type FVB/n controls.
Results from representative transgenic andwild-type animals are
presented since bisulfite-sequencing data were, in fact, identical
for the endogenous ROSA26 sequence in all the animals (Fig. 3).
In the 45 bisulfite-PCR subclones of the endogenous ROSA26
locus analyzed from three wild-type FVB/n mice, only 3
sporadic methylated CpGs were observed. The absence of CpG
methylation at the endogenous ROSA26 loci was in sharp
contrast to the high level of DNA methylation observed at the
identical sequence within T/MPT-eGFP in the same animals
(Fig. 2). The results clearly indicate that DNA methylation can
be introduced selectively into SB Tns inserted in the mouse
genome.
Hypomethylation at a neighboring host genomic region
The DNA methylation status of host genomic regions pro-
ximal to the inserted T/MPT-eGFP was characterized in several
transgenic animals. T/MPT-eGFP insertion 01-0001 was located
on chromosome 8 and had five CpG dinucleotides in the
flanking ∼600 bp of genomic DNA. The methylation pattern of
the five CpGs was assessed in the transgenic animal homo-
zygous for the insertion 01-0001 and in three wild-type FVB/n
mice without SB insertions (Fig. 4). This flanking region was
significantly hypomethylated at all the CpGs adjacent to the 01-
0001 insertion in the transgenic animal, compared to the iden-
tical region in the wild-type mice. This was in dramatic contrast
to the high level of DNA methylation detected at the cargo
sequence of T/MPT-eGFP (01-0001, Fig. 2). Moreover, unlike
the different levels of methylation observed at the CpGs in the
wild-type mice, the level of hypomethylation observed was
consistent at all five CpGs. This suggests that the SB insertion
triggered hypomethylation of the flanking genomic CpGs
irrespective of their initial level of methylation or distance
from the insertion site. The chromosomal DNA flanking the
insertion 01-0001 on the opposite side was also investigated, and
a similar pattern of CpG methylation was observed for both the
transgenic animal and the wild-type controls (data not shown).
Loss of detectable CpG methylation in the genomic region
flanking an SB insertion
More extensive hypomethylation was observed in the geno-
mic region adjacent to the insertion 01-0032 on mouse chro-
mosome 6 (Fig. 5). Only DNA from transgenic animals
heterozygous for this insertion was available because homozy-
gous animals were embryonic lethal from the Tn insertion into
Fig. 2. DNA methylation pattern of ROSA26 and the eGFP reporter gene of T/MPT-eGFP in the mouse genome. Bisulfite-mediated sequencing was applied to
genomic DNA isolated from tail clips of each transgenic animal. The map of T/MPT-eGFP is located above the DNA methylation profiles. The region that was
examined is indicated by expanded lines under the map. A roughly 500-bp stretch of DNA encompassing the 3′ portion of the ROSA26 promoter (∼320 bp) and initial
part of the eGFP transgene (∼170 bp) was subjected to bisulfite sequencing. The region, included in a large CpG island, contained a total of 57 CpGs. Each horizontal
line of circles in the profile represents a bisulfite-PCR subclone with filled circles and empty circles indicating methylated or unmethylated CpGs, respectively.
Bisulfite-PCR subclones were grouped into a block of lines according to the transgenic mouse harboring different T/MPT-eGFP insertions. The genotype of the T/
MPT-eGFP insertion (homo- or heterozygous), insertion number, and chromosomal location for each transgenic animal are described at left.
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distinguish between the wild-type allele and that containing
insertion 01-0032, bisulfite-PCR primers were designed to
amplify only the 01-0032 insertion allele using one primer lo-
cated in the Tn IR/DR sequence and the other enclosing the six
CpGs within ∼190 bp adjacent to this insertion site. The IR/DR
sequence amplified by this primer pair contained two CpGs so
that the bisulfite-PCR subclones contained eight CpGs. The
DNA methylation pattern of the wild-type allele was assessed
using different bisulfite-PCR primers designed to span the
identical neighboring region of 01-0032 without SB. Due to the
size limitation of the bisulfite-mediated PCR, this primer set
prevented amplification of the allele with the 3.2-kb T/MPT-
eGFP insertion. Thus, we were able to observe the methylation
pattern of the six CpGs at different alleles of the identicalgenomic region in an individual transgenic animal. Interestingly,
none of the eight CpGs were methylated in the 28 subclones
derived from the primers specific for the flanking genomic
region of the allele with the 01-0032 insertion (Fig. 5). In con-
trast, the wild-type allele in the same heterozygous transgenic
mouse exhibited a moderate level of CpG methylation similar to
that observed in the wild-type controls. The pattern of CpG
methylation obtained from both the wild-type animals and the
allele without the Tn clearly indicates that this region was
normally methylated in the absence of an SB insertion. Hence, it
appears that the mouse DNA methylation system can discrim-
inate between identical host genomic sequences depending on
the presence or absence of a nearby SB insertion. Together with
the results from host genomic regions flanking the insertion 01-
0001, our data suggest that SB transposition can induce either
Fig. 3. CpG methylation at the endogenous counterpart of ROSA26 sequence located on mouse chromosome 6. Genomic DNA isolated from tail clips of each
transgenic animal carrying T/MPT-eGFP insertions was subjected to bisulfite-mediated genomic sequencing. To discriminate the endogenous ROSA26 from that
introduced by T/MPT-eGFP, a ROSA26-specific bisulfite-PCR primer was exploited, yielding bisulfite-PCR subclones containing five additional CpGs specific only to
the endogenous ROSA26 sequence. Those five CpGs are indicated above the bisulfite-PCR subclones together with the 320-bp region identical with ROSA26 carried
by T/MPT-eGFP. For annotations of the CpG methylation profile, see legend to Fig. 2. DNA methylation of this endogenous ROSA26was also assessed for transgenic
animals heterozygous for insertion 01-0009 or insertion 01-0041 and two additional wild-type FVB/n mice. However, data from those animals also revealed the
complete lack of DNA methylation as presented here and consequently are not shown.
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genomic DNA. In addition, the heavy DNA methylation ob-
served in the T/MPT-eGFP at both chromosomal loci (Fig. 2)
indicates a demarcating boundary(s) in the Tn beyond which
CpG methylation is absent or rare.
CpG methylation at the flanking genomic regions of other
insertions
Two other distinct chromosomal T/MPT-eGFP insertion loci
were examined for possible changes in CpG methylation of the
flanking regions (Fig. 6). The bisulfite-PCR primer pair used to
amplify the genomic region adjacent to insertion 01-0024 also
amplified a portion of the IR/DR sequence of the Tn. At this
locus the flanking chromosomal sequence displayed a DNAmethylation pattern similar to that derived from wild-type
animals (Fig. 6A). The T/MPT-eGFP insertion 01-0041 also did
not significantly influence the CpG methylation status of the
adjacent host genomic DNA, as this region was densely methy-
lated regardless of Tn presence (Fig. 6B). Thus, the hypo-
methylation at the genomic regions of the insertions 01-0001
and 01-0032 was not universally observed for all T/MPT-eGFP
transpositions.
Discussion
In this study, we applied bisulfite-mediated genomic se-
quencing to transgenic FVB/n mice carrying SB Tn insertions to
identify potential changes in DNA methylation related to trans-
position into the mouse genome. Six independent insertions of
Fig. 5. Lack of CpG methylation at the flanking host genomic region of the
insertion 01-0032. A schematic map of the boundary region between the 01-0032
insertion and its adjacent host genomic region is indicated above the bisulfite-
sequencing data. The orientation of eGFP transcription is shown as an arrow
followed by an IR/DR of SB (empty thick arrow). The target TA dinucleotide of
SB insertion is also indicated. All six CpGs in the flanking region (vertical lines)
were within ∼190 bp of the insertion site. To discriminate the allele carrying the
insertion in the transgenic mouse heterozygous for the insertion 01-0032, one of
the bisulfite-PCR primers was designed within the IR/DR sequence, thus
enabling selective amplification of the insertion-carrying allele containing two
CpGs in the IR/DR and six CpGs in the neighboring host region ∼190 bp from
the insertion. Bisulfite-sequencing data for the allele without the insertion as well
as wild-type animals were obtained by using a primer pair that could amplify only
the region without insertion. For the annotations of bisulfite-sequencing data, see
Fig. 2 legend. The p value calculated byχ2 test with no methylation was <0.0001
for all the CpGs in the region.
Fig. 4. Hypomethylation at the neighboring host genomic region of the T/MPT-
eGFP insertion 01-0001. DNA methylation of five CpGs located at the flanking
genomic region of the insertion 01-0001 within ∼600 bp of the insertion was
investigated. Approximate locations of five CpGs at the flanking genomic
region are indicated by vertical lines (CpG) on the schematic map. Description
of the transgenic mouse and three different wild-type mice is given at the right of
each bisulfite-PCR subclone group. For the bisulfite-PCR subclone data, see the
legend to Fig. 2. CpG methylation patterns should be compared between the
transgenic mouse carrying the insertion 01-0001 and the wild-type animals as
controls without SB insertions. Statistical significance for the number of
methylated CpGs was determined by χ2 test for each CpG position. *p = 0.046;
§p = 0.0002; ‡p < 0.0001.
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that SB Tns inserted into the mouse genome can be selectively
methylated in marked contrast to the absence of CpG methy-
lation in the identical DNA sequence at the endogenous
chromosomal loci. In addition, our data also provide evidence
for significant changes in the DNA methylation of the mouse
genomic regions flanking SB insertion sites.
Foreign DNA elements such as retroviral LTRs have been
reported to be susceptible to de novo DNA methylation when
inserted into mammalian genomes [6,7,9]. This phenomenon
was also observed in transgenic mouse strains generated by
random integration of transgene arrays driven by various endo-
genous mouse promoters [39,40]. In those studies, although theendogenous mouse promoter sequence was unmethylated, the
identical DNA sequence integrated at various loci was methy-
lated according to copy number of the transgene insertions.
Fig. 6. Flanking host genomic regions showing DNA methylation patterns similar to those of wild type without SB insertions. Schematic map and relevant CpG
methylation profile of two independent T/MPT-eGFP insertions (01-0024 and 01-0041) are represented. (A) For the insertion 01-0024, three CpGs in the flanking
region were investigated for methylation in the mouse homozygous for the insertion as well as in the wild-type animal. Bisulfite-PCR products from the homozygous
transgenic animal include two additional CpGs from IR/DR (empty thick arrow), using an IR/DR-specific primer. The orientation of the eGFP transgene transcription
is indicated by a horizontal arrow adjacent to the IR/DR on the map. See legend to Fig. 2 for the details of bisulfite-sequencing data. The combined wild-type control
data were derived from three individual FVB/n mice. (B) The methylation of four CpGs in the flanking region of the insertion 01-0041 was assessed in the transgenic
animal homozygous for the insertion as well as in the wild-type animals. The assessed CpGs are located ∼650 bp from the insertion. The direction of eGFP
transcription is indicated above the insertion site. Other details are similar to those of (A).
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lation phenomenon was observed with single-copy transgene
insertions into the mouse genome by SB transposase.
We compared the DNA methylation pattern of the ROSA26
promoter carried by an SB Tn (T/MPT-eGFP) directly with that
of the endogenous ROSA26 sequence at its native chromosomal
locus distinct from the SB insertion sites. The high level of CpG
methylation of ROSA26 at the inserted T/MPT-eGFP was in
marked contrast to the absence of CpG methylation at the iden-
tical endogenous ROSA26 sequence in the same transgenic
animals. Therefore, our results provide solid evidence that a
transposed SB Tn can be a specific target for epigenetic modifi-
cation such as DNAmethylation in the host genome. A previous
study reported CpG methylation of a CAG-eGFP transgene
cassette inserted into the host genome of mouse germ cells via
SB transposition [41]. However, the CpG methylation of only
two HpaII sites located at eGFP was described in that report,
whereas our study examined the methylation status of 57 CpGs
within T/MPT-eGFP. Furthermore, the synthetic CAG promoter
used for the eGFP transgene [42,43] had no identical mouse
endogenous counterpart to which the DNA methylation pattern
could be compared [41]. Our data demonstrate conclusively that
differential methylation of the identical promoter sequence can
result from SB-mediated transgene insertion into the genome.
Currently, many parameters could be considered critical for
the discrimination of identical sequences by the DNA methy-
lation system. The chromosomal locus of the T/MPT-eGFP
insertion is not likely to be a crucial factor for the DNA
methylation of ROSA26, since high levels of CpG methylation
were detected in many different insertions of SB at a variety of
chromosomal loci. We previously observed no significant levelof CpG methylation at inserted SB Tns carrying a transgene
comprised of a human K14 promoter and Agouti reporter gene in
the C57BL/6 strain of inbred mice [44]. That finding, combined
with the present results, suggests that the IR/DR sequences
outside the SB Tn cargo DNA do not seem to influence CpG
methylation status. In fact, the Agouti transgene was almost free
of CpG methylation in the previous study. Therefore, the cargo
sequence contained within the SB Tn most likely determines
whether the inserted SB is susceptible to DNA methylation.
Moreover, two of the T/MPT-eGFP insertions (01-0009 and 01-
0024) displayed CpG methylation patterns implying a spread
from the eGFP sequence as if it was the core sequence element
triggering de novo DNA methylation. This is consistent with a
recent report in which the eGFP reporter gene with its high CpG
content mediated gene silencing through CpG dinucleotides
[45]. Strain-specific epigenetic modification of the Tn cargo due
to the genetic background of transgenic animals should also be
considered. In part, this is because a different genetic
background of inbred mouse strain was used in the previous
study [44], and the DNA methylation pattern of foreign
transgenes appears to be modulated according to trans factors
of the host genetic background [46,47]. However, the clarifica-
tion of precise mechanisms of CpG methylation by SB cargo
sequence or host genetic backgrounds would require more
comprehensive study with a variety of combinations of cargo
sequences as well as different inbred host genetic backgrounds
for the SB Tn.
The DNA methylation pattern of the 01-0024 Tn insertion
appeared reminiscent of genomic imprinting patterns of DNA
methylation, in that almost 50% of the bisulfite clones showed
dense methylation and 50% showed relatively little CpG
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clusters within the genome (http://www.mgu.har.mrc.ac.uk/
research/imprinting/largemap.html); and insertion 01-0024 is
located in mouse chromosome 7 on which a number of im-
printed loci exist. We examined a database of imprinted genes
(http://www.otago.ac.nz/IGC) [48] to determine if insertion 01-
0024 was, in fact, located near a block of imprinted genes. The
closest region of genomic imprinting, with genes such as Snrpn
and Necdin, was located ∼30 Mb from 01-0024, suggesting that
the transgene was not located in that region of chromosome 7.
However, another database of candidate genes (http://fantom2.
gsc.riken.jp/EICODB/) [49] indicated that there are two
maternally imprinted genes (RIKEN clone IDs F830048D03
and A130035I15) on chromosome 7 approximately 1 to 0.5 Mb
from the insertion site. Within this distance, it is conceivable
that methylation of Tn at the 01-0024 insertion site could be
controlled by genomic imprinting. Unfortunately, as discussed
below, insertion 01-0024 does not support expression of the
eGFP reporter gene, making it impossible to analyze the im-
printed pattern of this transgene. Moreover, in the FVB/n inbred
strain, the genetic polymorphism that would be essential for
allele-specific methylation or expression analysis is virtually
absent. Thus, further out-crossing of the transgenic lines onto
other strain backgrounds would be required to investigate
genomic imprinting at this insertion site.
In addition to strain background effects, it has been reported
that generational changes in the methylation status of a transgene
array can be associated with its expression in transgenic mice
[50,51]. This suggests that the DNA methylation pattern of the
inserted SB in the mouse genome could change due to
reproduction of the transgenic lines. This issue will also need
to be addressed by investigating multiple generations of the
transgenic lines from the SB Tn founder mice.
A correlation between the expression of eGFP and CpG
methylation ofROSA26 as well as eGFP itself is unclear because
of the poly(A)-trap structure of T/MPT-eGFP. For eGFP expres-
sion, T/MPT-eGFP should be inserted into an intron since the
transgene has no authentic poly(A) signal. Lack of a poly(A) tail
would limit the stability of the transcript [52]. To obtain an
appropriate poly(A) signal via splicing, the eGFP in T/MPT-
eGFP should be followed by an endogenous exon in correct
transcriptional orientation. Among the SB insertions analyzed in
this study, only two (01-0009 and 01-0032) had the correct
insertional topology to support the splicing and production of
polyadenylated eGFP reporter mRNA. For the insertion 01-
0032, a fusion transcript between eGFP and the downstream
exons was detected by RT-PCR in lung, thymus, and spleen of
the heterozygous animal [21]. However, RT-PCR is so sensitive
that the detected fusion transcript may have resulted from leaky
transcriptional repression caused by the heavy DNAmethylation
observed in eGFP and ROSA26 of the insertion 01-0032.
Additionally, DNA methylation at T/MPT-eGFP may explain
the low level of eGFP expression detected in peripheral blood
leukocytes of the transgenic founder animals used in this study
[22].
Another unique finding of our present study is the hypo-
methylation or no CpGmethylation at the flanking host genomicsequences of certain SB Tn insertions. Wild-type levels of CpG
methylation were either significantly reduced (insertion 01-
0001) or completely absent (insertion 01-0032) at the flanking
regions. However, the inserted SB elements were densely
methylated. This suggests that the high level of DNA methy-
lation within the inserted SB (T/MPT-eGFP) was unable to
spread across the boundary between the SB Tn and the neigh-
boring genomic regions. Previous reports have described
demethylation at host genomic sequences with Rous sarcoma
retroviral and Ad12 adenoviral DNA. Each displayed a close
correlation between the CpG methylation status of the inserted
viral genome and that of host flanking sequences [53,54],
suggesting similar levels of demethylation. In our study, geno-
mic alleles of the same chromosomal locus demonstrated sharply
contrasting DNA methylation patterns in the same transgenic
animal, depending on the presence of an SB insertion at the locus
(Fig. 5, insertion 01-0032). This indicates that SB insertion could
play a role as a genomic mark that enables the cellular epigenetic
modification system to discriminate between alleles at the same
chromosomal locus.
The parameters that can trigger demethylation at the host-
flanking region are not entirely known. In fact, many of the T/
MPT-eGFP insertions retained DNA methylation levels and
patterns similar to those of the wild-type controls. In addition,
the insertion 01-0001 displayed hypomethylation at the flanking
region adjacent to only one IR/DR, whereas another chromo-
somal region flanking the other IR/DR displayed a “wild-type”
methylation pattern. Moreover, the alteration in methylation
status of both the Tn and the flanking genomic regions was
independent of whether the insertion was in a gene or within an
intergenic region. The transition from hypermethylation to
hypo- or demethylation must have occurred before the IR/DR of
SB since two CpGs in the IR/DR of insertion 01-0032 displayed
no CpG methylation at all. Thus, there must be a demarcating
boundary in the T/MPT-eGFP with respect to DNA methylation
for at least two T/MPT-eGFP insertions.
Recently, the SB transposon system was investigated as a
potential tool for insertional random mutagenesis [21,28]. With
disruption of an exon and its ORF, one would not expect the
methylation status of an integrated SB Tn to interfere with the
mutagenesis screening. However, if SB insertion occurs in an
intron or near a regulatory cis-element whose activity is closely
associated with DNA methylation, phenotypic screening and
correct mapping of the target gene could potentially be
influenced by DNA methylation as previously observed [55].
Thus, random mutagenesis via SB insertion could generate a
mutant phenotype resulting from cis methylation-dependent
interference with gene expression independent of the Tn inser-
tion site. Moreover, if gain-of-function occurs via expression of
a new transcript from within the Tn intronic site of SB insertion
[28], promoter silencing by CpG methylation could modulate
penetrance of the phenotype. This scenario for random mu-
tagenesis suggests that the previously reported generational
changes in the methylation status of a transgene array [50,51]
could affect the stability of the observed phenotype.
In conclusion, our study showed significant perturbation in
the DNA methylation pattern of the inserted SB Tns as well as
212 C.W. Park et al. / Genomics 88 (2006) 204–213the flanking host genomic regions. The modification of DNA
methylation may affect the expression of transgenes delivered
by the SB Tn system and influence the local chromosomal
transcriptional activity by changing the epigenetic structure of
the chromatin as well. Thus, our findings warrant further study
on a comprehensive scale to determine the potential epigenetic
consequence(s) of nonviral DNA insertion into mammalian
genomes.
Materials and methods
Transgenic animals
The transposon construct and transgenic animals were created as previously
described [21,22]. The poly(A)-trap Tn, T/MPT-eGFP, consists of a splice
acceptor from the human HPRT intron B, a bovine growth hormone poly(A)
sequence, the ROSA26 promoter [30,31] driving the eGFP-F (enhanced and
farnesylated green fluorescent protein) cDNA (from peGFP-F; Clontech
Laboratories, Inc., Mountain View, CA, USA), and a splice donor from the
rabbit β-globin gene. pCAGGS-SB10 encoding SB transposase was constructed
with the SB10 transposase gene driven by the CAGGS promoter composed of
chicken β-actin and cytomegalovirus immediate early promoter sequences
[42,43]. The linearized plasmid, pT/MPT-eGFP, was injected into the
pronucleus of one-cell embryos together with SB10 mRNA. The FVB/n inbred
mouse strain was used for the study, and transgenic lines carrying a multicopy
concatemer of T/MPT-eGFP were established. Other FVB/n transgenic lines that
expressed SB10 transposase ubiquitously were created with pCAGGS-SB10. By
cross-breeding, doubly transgenic mice harboring T/MPT-eGFP and the SB10
transposase gene were generated. Subsequent breeding on the FVB/n
background generated the transgenic mice used in this study, and chromosomal
annotation of SB insertions was performed as described previously [21].
Bisulfite-mediated genomic sequencing
Genomic DNA isolated from tail clips of the transgenic mice was digested
with restriction endonucleases that did not cut the region of interest. This
digestion reduced the overall length of the chromosomal DNA fragments to
ensure complete DNA denaturation during bisulfite treatment. Following
purification of the digested DNA, 2 μg of the recovered DNAwas subjected to
bisulfite treatment [29,35,36]. Briefly, DNAwas denatured in 0.3 M NaOH for
20 min at 42°C. A mixture of sodium bisulfite (Sigma–Aldrich, Inc., St. Louis,
MO, USA), urea [36], and hydroquinone (Sigma–Aldrich) was added to the
denatured DNA to final concentrations of 3.7 M sodium bisulfite, 5.8 M urea,
and 8.8 mM hydroquinone. This mixture was incubated in the dark for ∼12–
15 h at 55°C. DNA was subsequently purified using QIAEX II resin (Qiagen
Corp., Chatsworth, CA, USA), treated with 0.3 M NaOH for 20 min at 37°C,
and ethanol-precipitated overnight at −20°C using 3 M ammonium acetate, 1 μg
of carrier tRNA (Sigma–Aldrich), and 3 vol of ethanol. The DNAwas recovered
by centrifugation at 13,000 g for 30 min at 4°C, washed twice with 70% ethanol,
and finally resuspended in 30 μl of H2O. This material (∼2–4 μl) was used as
template for the following PCR amplification of the DNA regions of interest.
PCR primers for bisulfite-treated genomic DNA were designed from DNA
sequences converted by theMethprimer program [37], which converts every C to
T except C's in the CpG dinucleotides. Bisulfite PCR primers for ROSA26 and
eGFP in T/MPT-eGFPwere ROSAF4 (forward), 5′-TYGGTATTATTGTGTTG-
GYGGATTGG-3′ (Y = C or T), and MPTR1 (reverse), 5′-ACAAATAAACTT-
CAAAATCAACTTACC-3′; primers for the endogenous counterpart of ROSA26
were ROSAF4 (above, forward) and EndoRR2 (reverse), 5′-ACTATCTCA-
CAAAACRACTCCACCAC-3′ (R = G or A); those for the flanking genomic
region of the insertion 01-0001 were 0001F1 (forward), 5′-GAAATTAGGTTT-
TAATGAAGAGTAGTG-3′, and 0001R1 (reverse), 5′-CTTACCAAATACC-
CAATATTTATTCC-3′; primers for a part of the IR/DR and flanking genomic
region of the insertion 01-0032 were MPTSBF3 (forward), 5′-GATTTGTGT-
TATGTATAAAGTAGATG-3′, and 0032R (reverse), 5′-ACAATAAACTAT-
CCTCTACATTAACC-3′; those for the flanking region of 01-0032 with no
insertion were 32WTF (forward), 5′-GGTTAGTTATTATAGTGTTAGAAGG-3′, and 0032R (above, reverse); primers for the flanking IR/DR and adjacent host
genomic region of the insertion 01-0024 were RIROF (forward), 5′-GAA-
TGTGATGAAAGAAATAAAAGTTG-3′, and 24WTR (reverse), 5′-CAATAA-
CATATTACAATAAACACTTAC-3′; primers for the wild-type flanking region
of 01-0024 with no insertion were 24WTF3 (forward), 5′-TATAATGATTTA-
GTTAGTTGAAATTTG-3′, and 24WTR2 (reverse), 5′-TATACTATATAACA-
CACTACAACCTC-3′; and primers for the flanking genomic region of insertion
01-0041 were 0041F (forward), 5′-TGGTTGTAGAAGATTTAAAGTATAAG-
3′, and 0041R (reverse), 5′-TCATCCTTCAAAAACCCTTCCAATC-3′. PCRs
were performed with the Expand High Fidelity PCR system (Roche Diagnostics,
Inc., Indianapolis, IN, USA) and Touchgene Gradient thermal cycler (Techne,
Inc., Burlington, NJ, USA). All PCRs employed a hot start and used PCR cycles
consisting of 5 min at 94°C, 36 cycles of 25 s at 94°C, 20 s at 55°C, and 45 s at
72°C and a final extension of 5 min at 72°C. The primer annealing temperature
used for the PCR amplification of the DNA from the wild-type mice flanking the
insertion 01-0024 (24WTF3 and 24WTR2) was 53°C, not the usual 55°C.
PCR products were purified using the QIAquick gel extraction kit (Qiagen)
and subsequently subcloned into the pGEM-T Easy vector (Promega Corp.,
Madison, WI, USA). Bisulfite-PCR subclones were sequenced using the
standard SP6 upstream primer. All cytosine residues except those of CpG
dinucleotides in the DNA regions amplified were examined for complete
conversion to thymine residues. Rare bisulfite-PCR subclones demonstrating
unconverted cytosine residues not from CpG dinucleotides were excluded.
Statistical analysis
Data from wild-type animals was assumed to be representative of the
“normal” pattern of CpG methylation at the relevant region. Statistical analysis
using the χ2 test was performed to determine if the wild-type loci methylation
densities differed significantly from those present in the chromosomal regions
flanking the insertion sites. p ≤ 0.05 was considered significant.
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